Abstract |
A case of advanced maxillary ameloblastoma was successfully treated with combined intra-arterial chemotherapy ( Peplomycin, 85 mg) and radiotherapy (Co60, 7080 r). The tumour showed a remarkable shrinkage, and the patient survived. He is still alive and well at the time of this report. Carefully applied chemotherapy combined with radiotherapy has a useful role in the management of ameloblastoma especially in an advanced maxillary tumour. This report presents a typical example, which indicates that the ameloblastoma may not be an inherently radioresistant and chemoresistant tumour.
|
Authors | M Ueda, T Kaneda |
Journal | Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
(J Craniomaxillofac Surg)
Vol. 19
Issue 6
Pg. 272-4
(Aug 1991)
ISSN: 1010-5182 [Print] Scotland |
PMID | 1719032
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antibiotics, Antineoplastic
- Cobalt Radioisotopes
- Bleomycin
- Peplomycin
|
Topics |
- Ameloblastoma
(drug therapy, radiotherapy)
- Antibiotics, Antineoplastic
(administration & dosage, therapeutic use)
- Bleomycin
(administration & dosage, therapeutic use)
- Cobalt Radioisotopes
(therapeutic use)
- Combined Modality Therapy
- Humans
- Injections, Intra-Arterial
- Male
- Maxillary Neoplasms
(drug therapy, radiotherapy)
- Middle Aged
- Neoplasms, Second Primary
(drug therapy, radiotherapy)
- Peplomycin
|